Kidney Failure Treatment: Acute vs. Chronic Management Strategies

Treatment differs fundamentally between acute kidney injury (AKI) and chronic kidney disease (CKD).

Acute Kidney Injury (AKI) – Reversible Goal

Immediate Priorities

  • Identify & treat cause: Pre-renal (volume, sepsis), Intrinsic (ATN, GN, AIN), Post-renal (obstruction)
  • Volume resuscitation (crystalloids); vasopressors if septic
  • Nephrotoxin avoidance (NSAIDs, aminoglycosides, contrast, ACEi/ARB hold)

Renal Replacement Therapy (RRT) Indications

  • AEIOU: Acidosis (pH<7.15), Electrolytes (K>6.5), Intoxication (dialyzable), Overload (pulmonary edema), Uremia (pericarditis, encephalopathy, bleeding)
  • Modalities: Intermittent HD, CRRT (hemodynamically unstable), SLED, PD

Supportive Care

  • Fluid/electrolyte balance, nutrition (1.2–1.5 g/kg protein), glycemic control, infection prevention

Chronic Kidney Disease (CKD) – Progression Delay

Staging (KDIGO)

G1–G5 by eGFR; A1–A3 by albuminuria. Risk stratification guides referral.

Disease-Modifying Interventions

  • RAAS blockade (ACEi/ARB) – proteinuric CKD, diabetic kidney disease
  • SGLT2 inhibitors (dapagliflozin, empagliflozin) – CKD with/without DM; ↓ progression, CV events
  • nsMRA (finerenone) – diabetic CKD
  • BP target <130/80 (KDIGO 2021)
  • Glycemic control (HbA1c ~7%)
  • Lifestyle: Plant-dominant diet, sodium <2g, exercise, smoking cessation, weight management

Complication Management

  • Anemia: ESA + iron (target Hb 10–11.5)
  • MBD: Phosphate binders, vitamin D analogs, calcimimetics
  • Acidosis: Sodium bicarbonate if <22 mmol/L

Kidney Replacement Therapy (KRT)

  • Dialysis (HD/PD): Start when symptomatic (uremia, volume, K) or eGFR ~5–10
  • Transplant: Preemptive ideal; living donor > deceased; evaluation early
  • Conservative management: Symptom-focused for frail/elderly

Nephrology referral at CKD G3b (eGFR<45) or A3 improves outcomes.

Kidney Disease - Related Articles